Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells

M Loudovaris1, M Hansen, Y Suen

  • 1Nexell Therapeutics, Inc., Cell Biology, Irvine, CA 92618, USA. mloudovaris@nexell.com

Related Concept Videos